Bausch Health Companies Inc. (TSE:BHC – Get Free Report)’s stock price hit a new 52-week high during trading on Wednesday . The company traded as high as C$13.88 and last traded at C$13.75, with a volume of 250971 shares. The stock had previously closed at C$13.40.
Wall Street Analyst Weigh In
Separately, Royal Bank of Canada increased their price target on shares of Bausch Health Companies from C$8.00 to C$9.00 and gave the stock a “sector perform” rating in a report on Friday, February 23rd.
Check Out Our Latest Stock Report on BHC
Bausch Health Companies Stock Up 0.8 %
Bausch Health Companies (TSE:BHC – Get Free Report) last issued its quarterly earnings results on Thursday, February 22nd. The company reported C$1.55 EPS for the quarter, topping analysts’ consensus estimates of C$1.36 by C$0.19. Bausch Health Companies had a negative net margin of 6.76% and a negative return on equity of 686.52%. The firm had revenue of C$3.28 billion for the quarter, compared to analyst estimates of C$3.05 billion. As a group, research analysts forecast that Bausch Health Companies Inc. will post 4.9609375 earnings per share for the current fiscal year.
About Bausch Health Companies
Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.
Featured Articles
- Five stocks we like better than Bausch Health Companies
- ESG Stocks, What Investors Should Know
- 3 Value Stocks Too Small For Buffett’s Portfolio
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Foot Locker Builds Up Another Head of Steam; Gains Imminent
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Disney Stock Catches 3 Upgrades In a Single Week
Receive News & Ratings for Bausch Health Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bausch Health Companies and related companies with MarketBeat.com's FREE daily email newsletter.